Optimi Health Corp. Common Shares is trading 6.2% up at $4.83 as global equities and growth names surge following a tentative 60-day U.S.-Iran peace agreement that reopened the Strait of Hormuz.
- The stock is extending its recent rebound following its May Nasdaq uplisting and a US$15 million oversubscribed equity offering.
- Gains are further supported by recent progress on the company's ibogaine psychedelic drug initiative, which was highlighted in a June 8 update.